A. W.
- Country
- The Netherlands
- Department
- Rheumatology
Research Overview
- Evaluation of a Personalized Treatment Strategy Versus Standard Care in Rheumatoid Arthritis Using Methotrexate, Golimumab, and Hydroxychloroquine Sulfate
- Concentration-Guided Tocilizumab Dose Reduction Versus Standard Dosing in Rheumatoid Arthritis: A Randomized, International, Multicenter, Non-Inferiority Trial
Data & Insights
Has run more than one trial at 2 of 15 partner sites.
Specializations
Rheumatoid Arthritis Management
This investigator specializes in developing innovative treatment approaches for rheumatoid arthritis, with particular emphasis on personalized medicine strategies that consider individual patient characteristics.
- Autoantibody-guided treatment
- Glucocorticoid response assessment
- JAK inhibitor therapy
The research focuses on optimizing treatment outcomes while considering both clinical effectiveness and economic implications.
Treatment Optimization
Expertise in the optimization of biological therapies for rheumatoid arthritis, with specific focus on tocilizumab dosing strategies and treatment intervals.
- Disease activity monitoring
- Serum concentration analysis
- Dose adjustment protocols
The investigator evaluates treatment efficacy through comprehensive disease activity assessments and biomarker monitoring.
Clinical Assessment
Specialized in evaluating treatment outcomes using disease activity measurements and implementing evidence-based assessment tools.
- DAS28-ESR monitoring
- Treatment response evaluation
- Cost-effectiveness analysis
The research incorporates both clinical and economic outcomes in treatment evaluation protocols.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.